Full NamePositionOrganizationTerm StartTerm End
Keith Wonnacott, PhDChairLexeo Therapeutics6/1/20215/31/2022
Angela N. Johnson, MBA MSMemberSigilon6/1/20215/31/2024
Adora Ndu, JD, PhDMemberBioMarin Pharmaceutical6/1/20215/31/2022
Scott V. McGoohan, JD, BSMemberVertex Pharmaceuticals6/1/20195/31/2022
Jan E. ThirkettleMemberPlatform Strategy Consulting Ltd6/1/20205/31/2023
Juliana Muscat, PhDMemberVertex Pharmaceuticals6/1/20195/31/2022
Victor Paulus, PhDMemberAbeona Therapeutics6/1/20195/31/2022
Michael Havert, PhDMember 6/1/20195/31/2022
Daniela Drago, PhDMemberAurion Biotech6/1/20205/31/2023
Megan Zoschg Canniere, PharmDMemberSpark Therapeutics6/1/20205/31/2023
Kit L. Shaw, PhDMemberDana-Farber Cancer Institute6/1/20195/31/2022
Timothy K. MacLachlan, PhDMemberNovartis6/1/20215/31/2024
S. Kaye Spratt, PhDMemberBridgeBio Gene Therapy6/1/20195/31/2022
Kathleen MeyerMemberSangamo Therapeutics, Inc.6/1/20165/31/2022
Anna R. Kwilas, PhDMemberFood and Drug Administration6/1/20165/31/2022
Robert G. PietruskoMemberVoyager Therapeutics, Inc.6/1/20195/31/2022
Sandhya SandujaMemberUS Food and Drug Administration6/1/20195/31/2022
Samantha KayStaff LiaisonASGCT6/1/20185/31/2045
Caitlin McCombsStaff LiaisonASGCT12/1/20215/31/2045